Home Trending Stocks Cassava Sciences, Inc. (SAVA) Stock Prices on the Rise After Success of...

Cassava Sciences, Inc. (SAVA) Stock Prices on the Rise After Success of Clinical Trials

Cassava Sciences, Inc. (SAVA) stock prices were up 5.61% as of market close on April 26th 2021, bringing the price per share up to USD$41.81 at the end of the trading day. Subsequent current market fluctuations saw the stock price climb 3.78% to it USD$43.39.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

SAVA’s Net Loss

In their recently disclosed financial reports for Q1 2021, SAVA reported a net loss of USD$3.5 million, a significant increase from their reported net loss of USD$1.2 million in the same period over the previous year. Net loss per share came out to USD$0.09 for Q1 2020, an increase from the USD$0.05 net loss per share reported in Q1 2020.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

SAVA’s Registered Direct Offering

Earlier in February 2021, SAVA announced the closing of its registered direct offering. The offering saw the company put up 4,081,633 shares of its common stock for sale, at a price per share of USD$49. Gross proceeds came out to nearly USD$200 million, with net proceeds of roughly USD$189.7 million after the deduction of costs associated with the offering.

Solid Liquidity Position for SAVA

The company reported USD$282.2 million in cash and cash equivalents as of March 31st 2021, with no outstanding debt. This is compared to the USD$93.5 reported as of December 31st, 2020. SAVA anticipates net cash use for upcoming operations throughout 2021 to be up to USD$25 million. This capital is anticipated to be allocated to personnel expenses associated with an increased workforce, manufacturing costs for the large-scale supply of drugs, and costs associated with clinical programs.

Positive Interim Analysis of Simufilam

On February 2nd, 2021, SAVA announced positive results for the first interim analysis that reported clinical data on a patient cohort being treated with simufilam. The cohort comprised the first 50 patients to have completed 6 months of open label treatment, with patients’ cognition scores having improved from baseline over the course of the 6 months of simufilam treatment. Consistent treatment presented no safety issues and showed a 10% mean improvement in cognition score from baseline to month 6.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for SAVA

Especially interesting is the company’s foray into the development of a treatment for the COVID-19 virus that is ravaging the global economy. Should the company be as successful in that endeavor as they have been in their other clinical trials, the outcome could be massively lucrative for SAVA and its investors. Investors are hopeful that the company will leverage its sturdy financial grounds and recent clinical progress to push for significant and sustained increases in shareholder value over the course of 2021.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.